Hypoxia and Hypoxia-Inducible Factors in Lymphedema

FRONTIERS IN PHARMACOLOGY(2022)

引用 4|浏览7
暂无评分
摘要
Lymphedema is a chronic inflammatory disorder characterized by edema, fat deposition, and fibrotic tissue remodeling. Despite significant advances in lymphatic biology research, our knowledge of lymphedema pathology is incomplete. Currently, there is no approved pharmacological therapy for this debilitating disease. Hypoxia is a recognized feature of inflammation, obesity, and fibrosis. Understanding hypoxia-regulated pathways in lymphedema may provide new insights into the pathobiology of this chronic disorder and help develop new medicinal treatments.
更多
查看译文
关键词
HIF, lymphedema, inflammation, lymphangiogensis, hypoxia
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要